Publicaciones en colaboración con investigadores/as de Hospital Universitario de Salamanca (8)

2016

  1. Gene–gene interactions between DRD3, MRP4 and CYP2B6 polymorphisms and its influence on the pharmacokinetic parameters of efavirenz in HIV infected patients

    Drug Metabolism and Pharmacokinetics, Vol. 31, Núm. 5, pp. 349-355

2011

  1. Population pharmacokinetic/pharmacogenetic model for optimization of Efavirenz therapy in caucasian HIV-infected patients

    Antimicrobial Agents and Chemotherapy, Vol. 55, Núm. 11, pp. 5314-5324

2009

  1. Influence of the cytochrome P450 2B6 genotype on population pharmacokinetics of efavirenz in human immunodeficiency virus patients

    Antimicrobial Agents and Chemotherapy, Vol. 53, Núm. 7, pp. 2791-2798

  2. Wernicke encephalopathy in alcoholics with diabetic ketoacidosis

    Internal Medicine, Vol. 48, Núm. 13, pp. 1187-1189

2008

  1. Adherence to highly active antiretroviral therapy in HIV-infected inmates

    Current HIV Research, Vol. 6, Núm. 2, pp. 164-170

  2. Protocolo diagnóstico de la hipertransaminasemia prolongada

    Medicine

2006

  1. Factors influencing adherence to highly active antiretroviral therapy in Spain

    Current HIV Research, Vol. 4, Núm. 2, pp. 221-227

1999

  1. Nevirapine-induced withdrawal symptoms in HIV patients on methadone maintenance programme: An alert [9]

    AIDS